Keyphrases
Pancreatic Neuroendocrine Tumors (pNETs)
100%
Von Hippel-Lindau Disease
60%
Rotenone Model
40%
Multiple Endocrine Neoplasia Type 1 (MEN1)
40%
Parkinson's Disease
40%
Catecholamine Biosynthesis
40%
3,4-Dihydroxyphenylacetaldehyde
35%
Pheochromocytoma
30%
Catecholaldehyde
30%
Peptide Receptor Radionuclide Therapy
30%
Germ Cells
28%
Paraganglioma
27%
Working Diagnosis
27%
Neurochemicals
25%
Patient Characteristics
24%
Pituitary Adenoma
23%
Rotenone
22%
Partial Response
21%
Free Hemoglobin
20%
International Criteria
20%
Locomotor
20%
Red Cell Mass
20%
Model Relevance
20%
Diagnostic Criteria
20%
Metastatic Thymoma
20%
Unique Characteristics
20%
Prognostic Marker
20%
Hemangioblastoma
20%
Prognostic Factors
20%
Primary Hyperparathyroidism (pHPT)
20%
CDKN1B
20%
Abnormal Pattern
20%
Normetanephrine
20%
Epigenetic Regulation
20%
Serum Phosphorus
20%
Hypopituitarism
20%
177Lu-DOTATATE
20%
Long-run Risk
20%
Interventional Management
20%
Non-interventional
20%
Ubiquitin-specific Protease 8
20%
Corticotroph Adenoma
20%
Immune Landscape
20%
Advanced Neuroendocrine Tumors
20%
Treatment Response
20%
Lutetium-177 (177Lu)
20%
DOTATATE
20%
Overall Outcome
20%
Dopamine
16%
All-cause Mortality
16%
Medicine and Dentistry
Pancreas Islet Cell Tumor
80%
Neuroendocrine Tumor
50%
Von Hippel-Lindau Disease
40%
Pituitary Adenoma
35%
Disease
33%
Pheochromocytoma
30%
Peptide Receptor
30%
Radionuclide Therapy
30%
Paraganglioma
27%
Hemangioblastoma
24%
Diagnosis
21%
CDKN1B
20%
Multiple Endocrine Neoplasia Type I
20%
Primary Hyperparathyroidism
20%
Thymoma
20%
Erythrocyte
20%
Multiple Endocrine Neoplasia
20%
Lutetium 177
20%
Prognostic Factor
20%
Hypopituitarism
20%
Normetanephrine
20%
Deubiquitinase
20%
Catecholamine Synthesis
20%
Somatics
20%
Acromegaly
20%
Lutetium
20%
Suprofen
20%
Treatment Response
20%
Neoplasm
16%
Family History
16%
All Cause Mortality
15%
Hematocrit
14%
Metanephrine
13%
Disease Exacerbation
12%
Clear Cell Renal Cell Carcinoma
12%
Intestine Injury
12%
Adenoma
12%
Methylation
10%
Medical Intervention
8%
Genetic Screening
8%
Hydrocortisone
8%
Recurrent Disease
8%
Odds Ratio
8%
Secretion (Process)
7%
Polycyclic Aromatic Hydrocarbon
7%
Genotype Phenotype Correlation
6%
Gallium 68
6%
Phenylethanolamine N Methyltransferase
6%
Kinase Signaling
6%
Retrospective Study
5%
